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Abstract

Introduction

The tissue response to implanted hydroxyapatite
(HAP) in rat alveolar bone was investigated using morphological and cytochemical approaches. High-resolution immunogold labeling was used to examine the distribution of two non-collagenous bone proteins, osteopontin and osteocalcin, and two plasma proteins, a 2HSglycoprotein (fetuin) and albumin. Glycoconjugates
were characterized by lectin-gold cytochemistry using
Ricinus communis I agglutinin and Wheat germ agglutinin. Transmission electron microscopy demonstrated
the presence of an electron-dense, lamina limitans-like
layer at the HAP particle-bone interface and organic material within the micropores of the particles. Mineral
was observed in relation to both these sites. The HAP
particle-bone interface was strongly immunoreactive for
osteopontin; moderately to weakly reactive for osteocalcin, a 2HS-glycoprotein and albumin, and rich in glycoconjugates containing galactose and/or N-acetyl-glucosamine/sialic acid. Organic material within the micropores of the HAP particles was also labeled with the
various antibodies and lectins. These results indicate
that the lamina limitans at the HAP particle-bone interface is enriched in osteopontin as well as in sugars
present in this and other molecules. Similarly, certain
bone and plasma proteins infiltrate the micropores of
HAP and distribute differentially throughout the
particles.

Hydroxyapatite (HAP), because of its biocompatibility, is commonly used as an implant material for bone
augmentation and reconstruction, and in particular for
dental applications (reviewed by Frame, 1987; Kenney
and Lekovic, 1991; Matukas et al., 1991). Substantial
information is available regarding the morphological
events that occur following implantation of HAP into
bone defects (Jarcho et al., 1977; de Lange, 1990). The
sequence of events that take place in response to HAP
include an inflammatory response that accompanies the
surgical procedure, formation of granulation tissue, deposition of bone and its subsequent mineralization, and ultimately bone remodeling (Krizek, 1983; Ziats et al.,
1988; Gross and Miiller-Mai, 1990).
Integration of a biomaterial is in part due to its interaction with the host tissue, an event which occurs at
the tissue-implant interface. Previous electron microscopic studies on HAP implanted into experimental bone
defects have shown the presence of an electron-dense,
granular layer at the HAP particle-bone interface
(Denissen et al., 1980; Jarcho, 1981; Ganeles et al.,
1986; de Lange et al., 1990; van Blitterswijk et al.,
1985, 1990; Ravaglioli et al., 1992). Although the origin and organic composition of this layer remain obscure, it has been speculated by these authors that it
might play an important role in HAP-bone interactions.
The purpose of this study was to examine, using a combination of morphological and cytochemical approaches,
the tissue response to HAP implanted into an alveolar
bone defect created in the rat maxilla. More specifically, we have focused on characterizing the extracellular matrix present at the HAP-bone interface.
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Materials and Methods
Experimental model
Male Wistar rats (Charles River, St.-Constant, QC)
weighing 200-250 g were used in this study. Threewalled periodontal osseous defects (approximately 1 mm
x 1 mm x 1 mm) were created along the palatal root of
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the maxillary first molar and sterile HAP particles (Kyocera, Kyoto, Japan) were implanted into the defects as
described previously (Kawaguchi et al. , 1992). Precipitated calcium-phosphate particles were sintered at 900°C
for 2 hours producing highly-crystalline HAP as determined by X-ray diffraction. Particles were a maximum
of 100 J.tm in diameter, had a 45% porosity, and the micropore diameter was approximately 100 nm as determined by transmission electron microscopy (TEM). The
animals were sacrificed at 2 and 3 weeks after implantation.

Tissue preparation for morphological analyses
Animals were fixed by perfusion through the heart
and into the aorta with 2.5% glutaraldehyde and 2% paraformaldehyde buffered with 0.1 M sodium cacodylate
(pH 7.3). The maxillae were dissected and immersed in
the same fixative at 4 °C for an additional 24 hours.
Some of the tissue specimens were decalcified in 10%
ethylenediaminetetraacetic acid (EDT A) for 2 months,
while others were prepared as non-decalcified samples.
After a brief washing with the same buffer containing
8% sucrose, tissues were post-fixed in 2% osmium tetroxide for 2 hours, dehydrated through a graded series
of ethanol followed by pure propylene oxide, and embedded in Epon 812. Thick sections (1-2 J.tm thick)
were cut with glass knives, stained with toluidine blue
and observed by light microscopy. Thin sections were
either left unstained or were stained with uranyl acetate
and lead citrate, and then examined with a JEOL JEM100S transmission electron microscope operated at an
accelerating voltage of 80 kV.
Some samples of the HAP particles were sputtercoated with gold and examined in a JEOL JSM-6300F
field emission scanning electron microscope (SEM)
operated at an accelerating voltage of 15 kV.

Figure 1. Scanning electron micrographs of hydroxyapatite (HAP) particles prior to implantation. The microporous nature of these polymorphic particles can be
observed at higher magnifications (inset). Bars = 50
J.tm and 0.5 J.tm (inset).

Immunocytochemical procedures
The protein A-gold method (reviewed by Bendayan,
1989) was used for immunocytochemical labeling of
bone and plasma proteins. Grid-mounted tissue sections
were first floated for 5 minutes on a drop of 0.01 M
phosphate-buffered saline (PBS) containing 1% ovalbumin (Sigma Chemical Co., St. Louis, MO). They
were then transferred and incubated for 1 hour at room
temperature on a drop of goat anti-rat osteopontin antiserum diluted 1:20 in PBS (Mizuno et al., 1991), goat
anti-rat osteocalcin antiserum diluted 1:50 in PBS
(Hauscbka et al., 1983), rabbit anti-rat a 2HS-glycoprotein (fetuin) antiserum diluted 1:30 in PBS (Mizuno et
al., 1991), or rabbit anti-rat serum albumin diluted 1:30
in PBS [Organon Teknika, Inc. (Cappel), Scarborough,
ON]. After antibody incubation, the thin sections were
washed in PBS and incubated with protein A-gold (8 or
14 nm in diameter) for 30 minutes at room temperature.
The grids were then washed with PBS and distilled
water. As controls, some sections were incubated with
protein A-gold alone, and non-immune serum or an unrelated antibody anti-amelogenin (Slavkin et al., 1982),

Tissue preparation for immunocytochemistry and
lectin cytochemistry
Animals were fixed by perfusion with 1% glutaraldehyde in 0.08 M sodium cacodylate buffer (pH 7.3)
containing 0.05% calcium chloride. After tissue dissection, the samples were additionally fixed by immersion
in the same fixative for another 3 hours at 4 °C. Following decalcification for 1 week in 0.5 N HCl containing 0.1% glutaraldehyde (McKee et al. , 1991), the samples were washed and dehydrated through a graded
series of ethanol and embedded in LR White resin
(Marivac, Halifax, NS). Thin sections of the tissues
were cut with a diamond knife, recovered on Formvarand carbon-coated nickel grids, processed for immunocytochemistry or lectin cytochemistry as described
below, and stained with uranyl acetate and lead citrate.
Sections were examined with a JEOL JEM-1200 EX-II
TEM operated at an accelerating voltage of 60 kV. ·
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Fig___ure 2. Light micrographs of surgical site 2 weeks after hydroxyapatite (HAP) implantation. A. HAP particles are
clearly visible within the bony defect situated between the alveolar bone (AB) and the tooth. A portion of the HAP particles closest to the remaining alveolar bone are surrounded by newly-formed, woven bone (arrowheads). B. At higher
magnification, the bone is associated with numerous osteoblasts (OB) and osteocytes (OC). HAP particles may be encased in bone (asterisks) or surrounded by other connective tissue elements and multinucleated giant cells (MNC). Bars
= 0.5 mm (A); and 50 ~-tm (B).
saccharides were purchased from Sigma.

followed by protein A-gold.
Lectin-gold cytochemical procedures

Results

Lectin-gold and glycoprotein-gold complexes were
prepared using 8 nm gold particles (Roth, 1983; Nanci
et al., 1989). Ricinus communis I agglutinin (RCA) was
directly coupled to the colloidal gold, while Wheat genn
agglutinin (WGA, Triticum vulgaris) binding was indirectly revealed using an ovomucoid-gold complex. RCA
is specific for galactose (Gal) and WGA for N-acetylglucosamine/sialic acid (GlcNAc/NeuNAc) (reviewed by
Benhamou, 1989). The grid-mounted tissue sections
were floated on either RCA-gold (diluted 1:20 in PBS)
for 1 hour or WGA (25 ~-tglml PBS) for 1 hour followed
by ovomucoid-gold (diluted 1:20 in PBS) for 30 minutes. As controls, grids were incubated with the lectins
in the presence of 0.2 M of their corresponding competing saccharides. The lectins, ovomucoid and competing

Morphological analyses
Observations of HAP particles by SEM prior to implantation showed that the particles varied greatly in size
and shape (Fig. 1). At 2 weeks after implantation, new
bone formation was observed around some of the HAP
particles within the alveolar bone defect (Fig. 2A).
Where bone had been deposited, numerous osteoblasts
and osteocytes were present, whereas multinucleated
cells were frequently observed in contact with HAP particles not yet surrounded by bone (Fig. 2B). In calcified
sections viewed by TEM, HAP particles consisted of a
polycrystalline mass (Fig. 3). At the outermost interface
between the bone and the HAP particles, there was a
mineralized layer differing in appearance from the
339
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Figure 4 (facing page, top). Transmission electron micrographs of the hydroxyapatite (HAP) particle surface
and bony interface following incubation of decalcified
thin sections with anti-osteopontin (OPN) and protein Agold complex. A and B. In regions where bone is absent and putative preosteoblasts (pOB) are found in the
vicinity of the HAP particles, when present, a thin (A)
or thick (B) lamina limitans-like layer of organic material that labels heavily for osteopontin can be observed at
the particle surface (arrows). Additional strong-to-moderate labeling is present over similarly-textured organic
material within the more peripheral micropores (arrowbeads) of the particle. C. Where bone matrix bas been
secreted by osteoblasts (OB) and is present at the particle surface (interface), numerous gold particles are additionally found over mineralized bone matrix (bracket).
N: nucleus. Bar = 1 JLm (the three micrographs are at
identical magnifications).
Figure 5 (facing page, bottom). Immunocytochemistry
of the hydroxyapatite (HAP) particle-bone interface using anti-osteopontin (OPN) antibody and protein A-gold.
A and B. Although the thickness of the lamina limitanslike layer at the HAP particle-bone interface varies considerably, strong osteopontin labeling is associated with
this structure (arrows) and with 'patches' (asterisks) in
the mineralized bone. Note also the osteopontin labeling
over organic material within the micropores (arrowheads). Inset in B shows background labeling of the interfacial region after a control incubation with unrelated
anti-amelogenin antibody. N: nucleus; OB: osteoblast.
Bars = 1 JLm .

Figure 3. Transmission electron micrograph of a calcified section at the hydroxyapatite (HAP) particle-bone
interface. Mineral (between arrows) is present at the
HAP particle surface and within the micropores (arrowbeads). Bar = 0.2 JLm.

Immunocytochemical labeling

mineral in the adjacent bone or in the HAP particle.
This mineralized layer appeared to extend into the micropores of the HAP particles (Fig. 3). Demineralized
sections of similar regions showed that the interfacial
layer consisted of an organic, lamina limitans-like layer
(Figs. 4-8; see a discussion of terminology regarding
laminae limitantes and cement lines in McKee and
Nanci , 1993), which in some places was continuous with
cement lines in bone and additional organic material
within the micropores. Indeed, the lamina limitans at
the surface of the particles, and the content of the superficial micropores, showed a similar electron density and
texture, and an apparent absence of collagen fibrils (Fig.
SB). Putative preosteoblasts (Fig. 4A) or bone (Figs. 58) were occasionally found in contact with this structure.
Although not always present, the lamina limitans showed
considerable variation in its thickness and continuity
(Fig. SA). Micropores near the HAP particle surface
generally showed a denser accumulation of organic
material than those of the innermost regions of the
particles (Fig. 7 A) .

Sections incubated with osteopontin antibody showed
numerous gold particles over the electron-dense, lamina
limitans-like layer at the surface of the HAP particles,
and over the organic matrix within the micropores (Figs.
4 and 5). Bone was also characteristically labeled with
this antibody over ' patches' of granular or reticular
material routinely found in mineralized bone ("grey
patches " ; discussed in McKee et al. , 1990, 1991). Osteoid showed little or no labeling. In addition, there was
a gradient of osteopontin labeling over the organic material within the micropores (Figs. 7 A and 7B), with the
number of gold particles varying in proportion to the
density of organic matrix. This labeling was greatest at
the periphery of the particles. Similar to the reaction
observed after incubation with anti-osteopontin, although
more diffuse and less intense, immunolabeling for osteocalcin was present over bone matrix and the organic
content of the micropores (Fig. 6A). Somewhat less labeling was seen over the lamina limitans at the HAP
particle-bone interface. With this antibody , the labeling
340
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Figure 8 (above). Lectin-gold cytochemistry showing binding sites for Ricinus communis I agglutinin (A, RCA) and
Wheat germ agglutinin (B, WGA) to reveal the sugar residues galactose and N-acetyl-glucosamine/sialic acid, respectively. Using these lectins, patches (asterisks) in mineralized bone, and organic material at the hydroxyapatite (HAP)
particle-bone interface (arrows) and in the micropores (arrowheads), all label intensely. Insets illustrate the interfacial
region in controls where sections were incubated with lectin and the corresponding competing saccharide. CP: cell
process. Bars = 1 I'm (A and B); and 0.5 J.'ID (insets).
anti-osteocalcin (compare Figs. 6A and 6B). Following
incubation of tissue sections with anti-albumin, the
lamina limitans and organic material within the micropores near the surface showed weak labeling, while the
content of the micropores in the more central portion of

of the intrapore material did not seem to correlate with
the density of organic material contained therein.
For plasma proteins, the labeling pattern obtained
after incubation with anti-a 2HS-glycoprotein was very
similar in distribution and intensity to that obtained with

Figure 6 (facing page, top). Similar interfacial region as in Figure 5 except after incubation with anti-osteocalcin (A,
OC), anti-a2HS-glycoprotein (fetuin; B, Pet) and anti-albumin (C, Alb). For osteocalcin and a 2HS-glycoprotein, moderate labeling is observed over mineralized bone, the electron-dense, lamina limitans-like layer at the hydroxyapatite
(HAP) particle-bone interface (arrows) and the content of the micropores (arrowheads). In both cases, the labeling
appears more diffuse than for osteopontin (compare to Figure 5). For albumin, some gold particles are present over
mineralized bone and the intrapore material , but practically no labeling is observed at the HAP particle-bone interface.
CP: cell process. Bars = 1 J.'m.

Figure 7 (facing page, bottom). Electron micrographs of the porous region of the hydroxyapatite (HAP) particles.
Intrapore organic material is generally denser at the periphery of each particle (bottom of each Figure), and diminishes
as a gradient more centrally (top of each Figure). Osteopontin (OPN) labeling (A, B) is greatest towards the periphery
of the particles, whereas albumin (Alb) labeling (C) is strongest more centrally. Bars = 1 I'm (A); 0.5 I'm (Band C).
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(Orr et al., 1992). This layer, however, was not consistently present at all sites around a particle and varied in
thickness. Similar data have been reported in other
experimental animal models (Neo et al., 1992) and in
clinical applications (van Blitterswijk et al., 1990). The
observed regional variation in the presence and thickness
of this interfacial layer may reflect substantial heterogeneity in both local cellular activity and extracellular
matrix events (McKee et al., 1992, 1993). Cultured
osteoblasts and bone marrow cells on HAP surfaces also
express an electron-dense layer at the HAP-mineralized
tissue interface (Brook et al., 1991; Sautier et al., 1991,
1992; de Bruijn et al., 1992).
The initial host response after HAP implantation is
generally marked by an inflammatory reaction (Krizek,
1983). During this early post-implantation phase, inflammatory cells and proteinaceous materials accumulate
in the vicinity of the implant and some of these proteins
adsorb onto the implant surface (Klein et al., 1980;
Gross and Miiller-Mai, 1990; Nishiyama et al., 1990).
Products released by the cells, including those adsorbed
onto the HAP surface, may change the properties of the
surface and, thereby, may influence subsequent events
(Thomsen and Ericson, 1991). Whether this initial layer
of adsorbed material persists following the various osteogenic activities that occur around the implanted material
is unclear. In this regard, prior to bone formation
around the HAP particles, multinucleated cells appear to
partially excavate both newly-formed bone and the HAP
particles themselves (Ogilvie et al., 19S7; Kawaguchi et
al., 1992; Takeshita et al., 1992; Baslt~ et al., 1993).
Although the tissue response may vary depending on the
exact nature of the ceramic implant material used, ultimately, the turnover of matrix components and mineral
that occurs during normal bone remodeling around an
implant is clearly another means by which an implantbone interface might be modified. Indeed, interfacial
adsorbed molecules may directly or indirectly mediate
these resorptive events.
Osteoblasts secrete various non-collagenous proteins
including osteopontin, a highly-phosphorylated, sulfated
glycoprotein found in bone and a number of other tissues
(reviewed by Butler, 1989; Sodek et al., 1992), and osteocalcin, a low-molecular weight, gamma-carboxyglutamic acid-containing protein (reviewed by Hauschka,
19S6; Cole and Hanley, 1991). Although the precise
roles of these non-collagenous bone proteins are still unknown, they have been shown to have a high affinity for
calcium ions and mineral (reviewed by Boskey, 1992;
Young et al., 1992). At the electron microscopic level,
immunocytochemical studies have characterized the distribution of these two proteins, and more recent reports
in chicken and rat have shown that osteopontin is concentrated at cement (reversal, resting) lines, the laminae

the HAP particle was more intensely labeled (Fig. 7C),
as was the surrounding bone matrix (Fig. 6C).
In all control incubations, only a few randomlydistributed gold particles were found over the tissue
sections (Fig. 5B, inset).
Lectin-gold labeling
RCA labeling showed an intense reaction over the
lamina limitans-like layer, 'patches' of mineralized bone
matrix and over the organic matrix within the micropores (Fig. SA). WGA showed a similar distribution of
gold particles, however, there also seemed to be an additional, more diffuse labeling over some regions of the
bone matrix (Fig. SB).
Control incubations, in the presence of the corresponding competing saccharide, resulted in a significant
reduction in labeling (Figs. SA, inset; SB, inset) .

Discussion
The present results show that during bone formation
around implanted HAP particles, an electron-dense, lamina limitans-like layer forms at the interface between the
bone and the HAP particles. This finding is consistent
with previous reports dealing with the HAP-bone interface in decalcified sections. Denissen et al. (19SO) and
Jarcho (19S1) reported the presence of an amorphous
"bonding zone" at the interface between bone and HAP.
This layer stained darkly with alcian blue, thus suggesting a proteoglycan content similar to that found in "natural bone cementing substance" (Jarcho et al., 1978).
Additional ultrastructural observations have been made
on this interfacial layer by Ganeles et al. (1986). Since
this electron-dense layer showed features similar to cement lines in bone, it has been speculated that it is similar in nature to this normal bone counterpart (Hench and
Paschall, 1974; van Blitterswijk et al., 1985, 1990; de
Lange et al., 1990; Davies et al., 1991; Ravaglioli et
al., 1992). Continuity between cement lines and laminae limitantes with the interfacial layer at the HAP particle surface was observed (data not shown). In agreement with previous reports (Frank et al., 1991; Neo et
al., 1992, 1993), we have observed the presence of a
distinct mineralized zone separating the HAP particle
from the bone matrix proper on sections of calcified material. Indeed, this interfacial layer, which is more
readily apparent in demineralized preparations (Daculsi
et al., 1990a), also extends within the micropores of the
HAP particles. In decalcified specimens, both these regions show the presence of organic material which labels
specifically for various bone non-collagenous and plasma
proteins. As for the bone-titanium interface in vivo
(Albrektsson et al., 19S3), implanted HAP rods are surrounded by a "cement line-like" layer which mineralizes
344
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limitantes at cell-lined bone surfaces and the bone/calcified cartilage interface (reviewed by McKee and Nanci,
1993). Based on the structural and functional properties
of osteopontin, it is probable that it plays a multifunctional role, including regulation of mineralization and
mediation of cell dynamics during osteogenic processes
(reviewed by Butler, 1989). However, where bone interfaces with biomaterials, such as HAP, little information is available concerning the nature of the interfacial
organic material. Here, we present immunocytochemical evidence showing that osteopontin, osteocalcin and
a 2HS-glycoprotein comprise, at least in part, the organic
layer at the HAP particle-bone interface. Osteopontin,
in particular, appears to be a major component of this
interfacial zone. The ultrastructure and composition of
the lamina limitans-like layer seen at the HAP particlebone interface, a structure similar to the planar arrangements of protein present as cement lines and laminae
limitantes in normal bone, suggest that this 'coating' of
protein (containing osteopontin as a major constituent)
may serve similar functions at implant surfaces with regard to adhesion, cell signalling and/or the regulation of
mineralization.
The osteopontin-containing lamina limitans at the
surface of the HAP particles was sometimes present
without adjacent osteoid and without the immediate presence of clearly identifiable cells of the osteoblastic
lineage. In these cases, it seems likely that osteogenic
cells, or other cells, in the vicinity of implanted HAP release osteopontin that subsequently diffuses to exposed
surfaces of mineral and functions at these more distant
sites. Polyanionic proteins, such as many of the noncollagenous bone proteins, when immobilized on a stable
support in vitro, induce and support mineral deposition
(Linde and Lussi, 1989). Therefore, it is conceivable
that some of the non-collagenous bone proteins, and in
particular osteopontin, by being immobilized onto the
surface of the particle itself, or onto the initial mineral
deposited onto the implanted HAP, may play a role in
the early mineralization events that occur at this site.
Some of the plasma proteins synthesized in the
liver, such as a 2HS-glycoprotein and albumin, are also
found in bone (Ashton et al., 1974; Triffitt and Owen,
1977; Smith et al., 1985). a 2HS-glycoprotein, in particular, is enriched in bone matrix and bas a strong affinity
for hydroxyapatite (Ashton et al., 1976; Mbuyi et al.,
1982). Furthermore, it has been suggested that a 2HSglycoprotein co-localizes with other bone matrix proteins, such as osteopontin and osteocalcin, and these
molecules may thus interact at sites of tissue mineralization (Ritter et al., 1992; McKee et al., 1993). In the
present study, the co-localization of these proteins in the
lamina limitans-like layer at the HAP particle-bone interface may like-wise reflect these potential mutual inter-

actions. Alternatively, it may simply reflect an affinity
of one or more of these proteins for the solid, mineral
phase of the HAP particle. However, more careful analysis of early events (i.e., less than 2 weeks) is necessary
to elucidate details of the initial sequence of appearance
of proteins at the interface and within the micropores.
The present lectin-gold cytochemical results demonstrate the presence of Gal and GlcNAc in the organic
matrix at the HAP-bone interface. Osteopontin, a glycoprotein having approximately 17% carbohydrate composition by weight, contains, among other post-translational
modifications, significant amounts of Gal sugar residues
(Prince et al., 1987). Thus, accumulation of osteopontin
in the extracellular matrix of bone and at the HAP-bone
interface clearly contributes to the labeling patterns observed here with RCA. Furthermore, the intense labeling obtained with WGA also indicates the presence of
other glycoconjugates at the sites of labeling. Considering the less specific, but nonetheless selective, nature of
lectin cytochemistry relative to immunocytochemistry, it
is reasonable to expect that additional, as yet unidentified classes of glycoconjugates exist at the interfacial
regions of implanted HAP. Further studies are required
to more fully characterize the organic material present at
these sites. Indeed, the selective binding of lectins may
be useful for the biochemical extraction and purification
of this material.
With regard to the material found within the micropores of the HAP particles, a previous ultrastructural
study on HAP implantation into human intrabony defects
showed the presence of a "honeycomb-like meshwork"
of organic material which extends from the electrondense, granular surface layer throughout the particle
(Ganeles et al., 1986). They speculated that this meshwork represents adsorption of organic material onto the
individual crystallites composing the particle, a process
occurring during infiltration of tissue fluids after implantation. With regard to the mineralization of the micropores, Ogilvie et al. (1987) reported that the overall
mineralization pattern within implanted HAP particles
occurs either from the surface outwards into the surrounding tissue, or from the 'inside out', in which calcification of the particle is initiated centrally and spreads
peripherally. Whichever the case, the formation of
small, needle-like microcrystals within the micropores
bas been demonstrated using a variety of different calcium-phosphate ceramics, regardless of the osseous or
non-osseous site of implantation (Daculsi et al., 1990b).
These investigators suggested that partial dissolution of
the implanted HAP releases calcium and phosphate ions,
thereby increasing local mineral ion concentrations to
levels capable of precipitating carbonato-apatite. Immediately following implantation, HAP particles are exposed to a myriad of molecules present in plasma and
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interfaces is a more general phenomenon similar to
events taking place at normally-occurring bone interfaces
(reviewed by McKee and Nanci, 1993).

tissue fluids. In addition to the more classical plasma
proteins such as albumin and a 2HS-glycoprotein, osteocalcin and possibly other bone proteins are like-wise
known to circulate within the bloodstream (reviewed by
Cole and Hanley, 1991). Tissue fluids bathing the particles at the time of implantation, and the subsequent inflammatory phase, undoubtedly provide the initial source
for protein adsorption onto, and protein infiltration into,
the HAP particles. Thus, depending on the rapidity and
extent to which proteins diffuse throughout the micropores of the HAP particles, the physico-chemical forces
driving the dissolution and re-precipitation of mineral
within the micropores (as discussed by Daculsi et al.,
1990b) may occur in the absence, or presence, of a proteinaceous milieu. However, it is generally accepted
that the normal physiological deposition of mineral in
most cases is guided by an organic matrix (reviewed by
Weiner, 1986). In the present study, we have shown the
co-existence of mineral and organic matrix within the
micropores, and have further identified some of the organic constituents contained therein (e.g., osteopontin,
osteocalcin, a 2HS-glycoprotein, and albumin). The
presence and interactions of the identified plasma and
non-collagenous bone proteins found at these sites most
likely influence this mineralization process.
It could be expected that the initial infiltration of
organic material into HAP implants may depend in part
on micropore and molecule size. The micropore size of
the HAP particles used in the current experiments was
approximately 100 nm, a dimension clearly large enough
to accommodate the proteins examined in this study.
Excluding differences in mineral affinity, it is reasonable
to assume that smaller proteins present in the tissue fluid
at the time of HAP implantation, or shortly thereafter,
may penetrate further into the particles. However, the
relatively low molecular weight (""' 6 kDa) of osteocalcin may only partially explain the deep penetration and
uniform distribution of this protein within the HAP particles since a larger molecule such as albumin is also
found in large amounts in the center of the HAP particles. With the arrival of osteoblasts and, following the
secretion of non-collagenous bone matrix proteins by
these cells, protein-protein and protein-mineral interactions undoubtedly influence the diffusion and accumulation of proteins within the micropores of the HAP particles. Based on similarities in the density, texture and
composition of the organic material within the more peripheral micropores and the lamina limitans-like layer
surrounding the HAP particle, it is probable that the
bulk of this material is similar, only adapting spatially to
the surrounding physical constraints afforded by the
three-dimensional architecture of the individual HAP
particles themselves. Ultimately, it would appear that
the accumulation of organic material at bone-implant
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Toronto Press, Toronto, pp. 214-228; and Davies JE,
Nagi N, Takeshita N, Smith DC (1991) Deposition of
cement-like matrix on implant materials. In: Bone-Riomaterials Interface. Davies JE (ed.). op. cit. pp. 285294].
Authors: At the time intervals examined (2 and 3
weeks), we have not observed such globular accretions,
although examination of the interface at earlier intervals
should provide some insight on the sequence of early
events occurring in our system as proposed by Davies et
al. (cited in the question) for the various implant
materials.

Discussion with Reviewers
C.A. van Blitterswijk: In earlier studies a lamina
limitans-like layer was also observed for the HAP/soft
tissue interface at some distance from osseous tissue.
Do the authors suspect that this layer would have a
similar proteinaceous content as the same structure at the
bonei HAP interface. If the answer to this question is
no, and in view of the fact that this fibrous tissue
interface is also calcified, then would it not seem
unlikely that such bone proteins are related with the
mineralization process at the HAP surface.
Authors: Since it is known that plasma proteins can adsorb onto hydroxyapatite [Ellingsen JE (1991) A study
on the mechanism of protein adsorption to Ti~. Riomaterials 12: 593-596], and despite the observation that
the soft-tissue-HAP interface appears to be calcified, the
lamina limitans-like layer at this interface may indeed
show a different composition from that found in a bony
environment. However, it cannot be excluded that noncollagenous bone proteins circulating in blood (e.g.,
osteocalcin) or proteins produced locally by mesenchymal cells may interact with the HAP resulting m
their accumulation at the surface of the material.

J.-M. Sautier: Several authors assume that there might
be a relationship between the bone bonding properties of
bioactive material and the composition of the lamina
limitans-like structure adjacent to HAP. Do you think
that the incorporation of organic components at the interface play a role in the bone-bonding process?
Authors: Whereas non-collagenous bone proteins are
known to bind tightly to mineral via certain structural
motifs (e.g., polyacidic amino acid domains), and although proteins are known to adsorb onto the surface of
biomaterials, the contribution to the "bone-bonding" and
biocompatibility process of proteins at the tissue-implant
interface remains to be determined. Since the implanted
particles sit amidst extensive osteogenic activity, it is
likely that some bone will be formed and its individual
proteins will be deposited on the particles. Indeed, osteoblasts may view the HAP surface as an interface between an older and a younger matrix, and thereby secrete the equivalent of a cement line onto the particles
[for further discussion, see: Nanci A, McCarthy GF,
Zalzal S, Clokie CML, Warshawsky H, McKee MD
(1994) Tissue response to titanium implants in the rat
tibia: Ultrastructural, immunocytochemical, and lectincytochemical characterization of the bone-titanium
interface. Cells and Materials, vol. 4, accepted for
publication]. However, when considering these processes related to different implants, it is reasonable to expect
that the surface characteristics of the implant itself play
a role in the interactions between the implant and bone
constituents.

C.A. van Blitterswijk: It is known that tricalcium
phosphate may show a focal deposit at its interface with
bone in contrast to the more continuous precipitations
with HAP. Do you think that this reflects a different
protein coating or is it related to variations in calcium
phosphate precipitations (HAP versus tri-calcium
phosphate).
Authors: Regarding the appearance of organic and inorganic material at an implant interface, conceptually,
there are several possibilities that can be envisaged.
Firstly, m initial coating of protein may influence subsequent mineralization events. Secondly, initial mineral
may spontaneously precipitate at the surface of the implant and subsequently interact with protein. A third
possibility would be that protein and mineral appear
simultaneously at the surface of the implant. It could be
expected that different materials may influence these

J.-M. Sautier: Intriguing is the fact that immunoreactivity for osteopontin was not localized inside the cell.
Do you think that this absence of labeling may be due to
the fact that osteopontin is expressed at an early stage of
bone cell differentiation and deposited into the extracellular matrix prior to mineralization or to the fact that, in
part, osteopontin is taken up from biological fluids?
Authors: Since non-collagenous proteins represent a
minor portion of the secretory output of osteogenic cells
and since during histological processing of tissues not all

processe~.

U.M. Gross: Is there evidence from your fmdings that
the different thickness and continuity of the lamina
limitans an be caused by the globular deposition of
mineral as described by Davies et al. [Davies JE,
Ottensmeyer P, Shen X, Hashimoto M, Peel SAF (1991)
Early ex:racellular matrix synthesis by bone cell. In:
Bone-Bicmaterials Interface. Davies JE (ed.). Univ.
349

H. Kawaguchi, M.D. McKee, H. Okamoto and A. Nanci

Authors: The apparent HAP particle, grain and micropore dimensions vary for calcified specimens visualized
by SEM or TEM when compared to histological preparations of decalcified tissues, in part because of the
tissue shrinkage known to occur during histological
processing.
Plane of section most probably also
contributes to the range of measurements observed.
Furthermore, smaller particles were not excluded from
the HAP preparations used in these studies.

antigenicity will be preserved, it is to be expected that
only cells with a significant, and perhaps maximal, synthetic activity will show unequivocal intracellular labeling for proteins such as osteopontin. In this regard, at
the post-implantation time intervals examined, the
lamina limitans was well-established, and therefore, cells
may no longer intensely produce its constituents, thus reducing the immunocytochemical probability of visualizing a reaction in cells. Indeed, even in normal untreated
bone, not all osteoblasts will show intracellular immunoreactivity for osteopontin, an observation which suggests
that these cells do not function synchronously, in accordance with current concepts of bone modeling and remodeling (reviewed in McKee and Nanci, 1993). Furthermore, we have recently obtained initial data (unpublished) suggesting that treatment of rats with drugs which
interfere with the intracellular processing or transport of
secretory products (e.g., vinblastine sulfate) may result
in an increase in the frequency of osteoblasts showing a
distinct intracellular immunoreactivity for osteopontin,
an observation consistent with the notion that the absence of immunolabeling in osteoblasts at the bone-HAP
interface may in part reflect cellular levels of protein
below the detection limit.

G.L. de Lange: What is the opinion of the authors with
regard to: (1) Dynamic events which take place at the
bone-implant interface? (2) Are there differences
between 2 or more weeks after implantation? and (3)
What gives the HAP the high bone biocompatibility? Is
this caused by non-specific adsorption of osteopontin/
osteocalcin and other glycoproteins, or is this due to a
more specific extracellular matrix production by osteoblastic cells?
Authors: The issues raised by these questions have
been addressed in the answers provided above for the
questions of Drs. van Blitterswijk, Gross, and Sautier.
G.L. de Lange: Do the authors have more information
on the connective tissue-HAP interface? What difference do they find comparing HAP particles embedded in
bone and in periodontal ligament? Do periodontal ligament fibroblasts have a different reaction on HAP compared with other (gingival) fibroblast?
Authors: We have not examined aspects of the soft
connective tissue-HAP reaction in the present study and
therefore, regretfully, cannot offer answers to these
questions.

J.E. Davies: One small, but troublesome, point arises
when comparing the scales of the various transmission
electron micrographs. If one measures the implant grain
size distribution in Figure 3, simple measurement yields
a range of 0.03 to 0.8 J.tm (approximately measured using a ruler and the scale bar provided). If one carries
out the same measurement in, for example, Figure 4 (a,
band c) then the voids (decalcified grains) yield a range
of 0.13 to 0.4 J.tm. This discrepancy applies to both the
other transmission electron micrographs and similar
measurements of the pore size. Please comment.
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